Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:49 UTC
Update Date2022-03-07 02:51:35 UTC
HMDB IDHMDB0014370
Secondary Accession Numbers
  • HMDB14370
Metabolite Identification
Common NameGadodiamide
DescriptionGadodiamide is only found in individuals that have used or taken this drug. It is a gadolinium based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. It is commonly marketed under the trade name Omniscan. [Wikipedia ]Based on the behavior of protons when placed in a strong magnetic field, which is interpreted and transformed into images by magnetic resonance (MR) instruments. Paramagnetic agents have unpaired electrons that generate a magnetic field about 700 times larger than the proton's field, thus disturbing the proton's local magnetic field. When the local magnetic field around a proton is disturbed, its relaxation process is altered. MR images are based on proton density and proton relaxation dynamics. MR instruments can record 2 different relaxation processes, the T1 (spin-lattice or longitudinal relaxation time) and the T2 (spin-spin or transverse relaxation time). In magnetic resonance imaging (MRI), visualization of normal and pathological brain tissue depends in part on variations in the radiofrequency signal intensity that occur with changes in proton density, alteration of the T1, and variation in the T2. When placed in a magnetic field, gadodiamide shortens both the T1 and the T2 relaxation times in tissues where it accumulates. At clinical doses, gadodiamide primarily affects the T1 relaxation time, thus producing an increase in signal intensity. Gadodiamide does not cross the intact blood-brain barrier; therefore, it does not accumulate in normal brain tissue or in central nervous system (CNS) lesions that have not caused an abnormal blood-brain barrier (e.g., cysts, mature post-operative scars). Abnormal vascularity or disruption of the blood-brain barrier allows accumulation of gadodiamide in lesions such as neoplasms, abscesses, and subacute infarcts.
Structure
Data?1582753170
Synonyms
ValueSource
Gadolinium 5,8-bis(carboxylatomethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-OateHMDB
Gadolinium [bis(2-{(carboxylatomethyl)[2-(methylamino)-2-oxoethyl]amino}ethyl)amino]acetateHMDB
Gadolinium 5,8-bis(carboxylatomethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-Oic acidHMDB
2-[Bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetic acid;gadolinium(3+)HMDB
Gadolinium [bis(2-{(carboxylatomethyl)[2-(methylamino)-2-oxoethyl]amino}ethyl)amino]acetic acidHMDB
Amersham brand OF gadodiamideHMDB
GD-DTPA bis-(methylamide)HMDB
GD-DTPA-bmaHMDB
Nycomed brand OF gadodiamideHMDB
OmniscanHMDB
Omniscan unique softpackHMDB
Sanofi winthrop brand OF gadodiamideHMDB
Gadolinium(7+) ion 2-[bis({2-[(carboxymethyl)[(methylcarboximidato)methyl]amino]ethyl})amino]acetic acidHMDB
Chemical FormulaC16H26GdN5O8
Average Molecular Weight573.66
Monoisotopic Molecular Weight574.10005
IUPAC Name3,13-bis(methylamino)-16,19,22-trioxo-2lambda4,14lambda4,15,20,23-pentaoxa-5lambda5,8lambda5,11lambda5-triaza-1-gadolinaheptacyclo[6.6.3.3^{1,5}.3^{1,11}.0^{1,5}.0^{1,8}.0^{1,11}]tricosa-2,13-diene-2,5,8,11,14-pentakis(ylium)-1-uide
Traditional Name3,13-bis(methylamino)-16,19,22-trioxo-2lambda4,14lambda4,15,20,23-pentaoxa-5lambda5,8lambda5,11lambda5-triaza-1-gadolinaheptacyclo[6.6.3.3^{1,5}.3^{1,11}.0^{1,5}.0^{1,8}.0^{1,11}]tricosa-2,13-diene-2,5,8,11,14-pentakis(ylium)-1-uide
CAS Registry Number122795-43-1
SMILES
O=C1O[Gd-]234567[O+]=C(C[N+]2(CC[N+]3(CC(O4)=O)CC[N+]5(CC(=[O+]6)NC)CC(=O)O7)C1)NC
InChI Identifier
InChI=1S/C16H29N5O8.Gd/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);/q;+7/p-3
InChI KeyKMRGYWHCSOXZMG-UHFFFAOYSA-K
Chemical Taxonomy
Description Belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon).
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentAlpha amino acids
Alternative Parents
Substituents
  • Alpha-amino acid
  • Tricarboxylic acid or derivatives
  • Amino acid
  • Tertiary aliphatic amine
  • Tertiary amine
  • Carboxylic acid salt
  • Carboxylic acid
  • Carboximidic acid derivative
  • Carboximidic acid
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organic salt
  • Organooxygen compound
  • Organonitrogen compound
  • Carbonyl group
  • Amine
  • Organic cation
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External DescriptorsNot Available
Ontology
Not AvailableNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP-5.1ChemAxon
pKa (Strongest Acidic)10.63ChemAxon
pKa (Strongest Basic)-5ChemAxon
Physiological Charge4ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area171.24 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity122.25 m³·mol⁻¹ChemAxon
Polarizability40.75 ųChemAxon
Number of Rings7ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+198.432859911
AllCCS[M+H-H2O]+197.332859911
AllCCS[M+NH4]+199.332859911
AllCCS[M+Na]+199.632859911
AllCCS[M-H]-223.732859911
AllCCS[M+Na-2H]-223.932859911
AllCCS[M+HCOO]-224.132859911

Predicted Kovats Retention Indices

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Gadodiamide,1TMS,isomer #1CNC1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C)=[O+]74080.5Semi standard non polar33892256
Gadodiamide,1TMS,isomer #1CNC1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C)=[O+]73607.8Standard non polar33892256
Gadodiamide,1TMS,isomer #1CNC1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C)=[O+]74807.7Standard polar33892256
Gadodiamide,2TMS,isomer #1CN(C1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C)=[O+]7)[Si](C)(C)C4146.3Semi standard non polar33892256
Gadodiamide,2TMS,isomer #1CN(C1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C)=[O+]7)[Si](C)(C)C3715.0Standard non polar33892256
Gadodiamide,2TMS,isomer #1CN(C1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C)=[O+]7)[Si](C)(C)C4862.5Standard polar33892256
Gadodiamide,1TBDMS,isomer #1CNC1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C(C)(C)C)=[O+]74281.8Semi standard non polar33892256
Gadodiamide,1TBDMS,isomer #1CNC1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C(C)(C)C)=[O+]73843.9Standard non polar33892256
Gadodiamide,1TBDMS,isomer #1CNC1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C(C)(C)C)=[O+]74951.3Standard polar33892256
Gadodiamide,2TBDMS,isomer #1CN(C1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C(C)(C)C)=[O+]7)[Si](C)(C)C(C)(C)C4565.2Semi standard non polar33892256
Gadodiamide,2TBDMS,isomer #1CN(C1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C(C)(C)C)=[O+]7)[Si](C)(C)C(C)(C)C4206.1Standard non polar33892256
Gadodiamide,2TBDMS,isomer #1CN(C1=[O+][Gd-]234567OC(=O)C[N+]2(CC[N+]3(CC(=O)O4)C1)CC[N+]5(CC(=O)O6)CC(N(C)[Si](C)(C)C(C)(C)C)=[O+]7)[Si](C)(C)C(C)(C)C5072.2Standard polar33892256
Spectra

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00225 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00225 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID54756
KEGG Compound IDC13106
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkGadodiamide
METLIN IDNot Available
PubChem Compound60754
PDB IDNot Available
ChEBI ID31642
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available